On Friday, April 24, 2026, I had the privilege of being one of six Notre Dame faculty selected to pitch at the inaugural Research Commercialization Grant (RCG) Pitch Event, hosted by the IDEA Center at Notre Dame in Leighton Hall at Innovation Park. The morning brought together external investors, the IDEA Center Advisory Council, and …
Category Archive: metastatic cancer cells
Apr 03
Society for Biomaterials – Seattle 2019
I was in Seattle for the week at the Society for Biomaterials 2019 conference. Excited to have data from three projects in four sessions at SFB 2019. Thanks to CTSI-PDT (#CTSI), ACS-IRG(#americancersociety), NDnano, AD&T and HCRI for their crucial support for these projects. 1. Rapid-Fire oral Presentation on Wednesday on April 3, 2019, from 4:05 …
Feb 14
American Cancer Society Seed Grant Awarded to us to Develop a Label-Free, Precise Chemotherapeutic Delivery to Metastatic Breast Cancer Cells In Vivo
We are extremely excited and thankful to the American Cancer Society and the Harper Cancer Research Institute for facilitating this seed grant for our work on label-free targeting of undruggable cancer cells. We intend to target non-targetable cancer cells by tuning the force exerted by label-free nanomaterials at the cell membrane to selectively permeabilize the …
NIH Funding Opportunities
- Notice to Rescind NOT-HL-24-008 "NHLBI Announces New Policies Regarding Budget Guidelines for SBIR/STTR Applications" May 13, 2026Notice NOT-HL-26-005 from the NIH Guide for Grants and Contracts
- Notice of Early Expiration of PAR-25-202 "Technology Development Research for Establishing Feasibility and Proof of Concept (R21 - Clinical Trial Not Allowed)" May 12, 2026Notice NOT-GM-26-005 from the NIH Guide for Grants and Contracts
Recent Comments